S&P 500   4,605.61 (+0.85%)
DOW   34,660.19 (+0.51%)
QQQ   396.12 (+0.58%)
AAPL   169.28 (+2.41%)
MSFT   335.92 (+1.61%)
FB   318.31 (-1.90%)
GOOGL   2,877.14 (+1.38%)
AMZN   3,507.88 (+0.02%)
TSLA   1,142.91 (-0.16%)
NVDA   324.25 (-0.77%)
BABA   125.34 (-1.72%)
NIO   39.64 (+1.30%)
CGC   10.37 (-3.17%)
AMD   154.77 (-2.27%)
GE   95.46 (+0.49%)
MU   87.59 (+4.27%)
T   22.57 (-1.14%)
F   20.05 (+4.48%)
DIS   144.97 (+0.05%)
PFE   54.55 (+1.53%)
ACB   6.25 (-2.65%)
AMC   32.70 (-3.65%)
BA   194.13 (-1.88%)
S&P 500   4,605.61 (+0.85%)
DOW   34,660.19 (+0.51%)
QQQ   396.12 (+0.58%)
AAPL   169.28 (+2.41%)
MSFT   335.92 (+1.61%)
FB   318.31 (-1.90%)
GOOGL   2,877.14 (+1.38%)
AMZN   3,507.88 (+0.02%)
TSLA   1,142.91 (-0.16%)
NVDA   324.25 (-0.77%)
BABA   125.34 (-1.72%)
NIO   39.64 (+1.30%)
CGC   10.37 (-3.17%)
AMD   154.77 (-2.27%)
GE   95.46 (+0.49%)
MU   87.59 (+4.27%)
T   22.57 (-1.14%)
F   20.05 (+4.48%)
DIS   144.97 (+0.05%)
PFE   54.55 (+1.53%)
ACB   6.25 (-2.65%)
AMC   32.70 (-3.65%)
BA   194.13 (-1.88%)
S&P 500   4,605.61 (+0.85%)
DOW   34,660.19 (+0.51%)
QQQ   396.12 (+0.58%)
AAPL   169.28 (+2.41%)
MSFT   335.92 (+1.61%)
FB   318.31 (-1.90%)
GOOGL   2,877.14 (+1.38%)
AMZN   3,507.88 (+0.02%)
TSLA   1,142.91 (-0.16%)
NVDA   324.25 (-0.77%)
BABA   125.34 (-1.72%)
NIO   39.64 (+1.30%)
CGC   10.37 (-3.17%)
AMD   154.77 (-2.27%)
GE   95.46 (+0.49%)
MU   87.59 (+4.27%)
T   22.57 (-1.14%)
F   20.05 (+4.48%)
DIS   144.97 (+0.05%)
PFE   54.55 (+1.53%)
ACB   6.25 (-2.65%)
AMC   32.70 (-3.65%)
BA   194.13 (-1.88%)
S&P 500   4,605.61 (+0.85%)
DOW   34,660.19 (+0.51%)
QQQ   396.12 (+0.58%)
AAPL   169.28 (+2.41%)
MSFT   335.92 (+1.61%)
FB   318.31 (-1.90%)
GOOGL   2,877.14 (+1.38%)
AMZN   3,507.88 (+0.02%)
TSLA   1,142.91 (-0.16%)
NVDA   324.25 (-0.77%)
BABA   125.34 (-1.72%)
NIO   39.64 (+1.30%)
CGC   10.37 (-3.17%)
AMD   154.77 (-2.27%)
GE   95.46 (+0.49%)
MU   87.59 (+4.27%)
T   22.57 (-1.14%)
F   20.05 (+4.48%)
DIS   144.97 (+0.05%)
PFE   54.55 (+1.53%)
ACB   6.25 (-2.65%)
AMC   32.70 (-3.65%)
BA   194.13 (-1.88%)
NASDAQ:ESPR

Esperion Therapeutics SEC Filings & 10K Form

$8.27
-0.46 (-5.27%)
(As of 12/1/2021 01:31 PM ET)
Add
Compare
Today's Range
$8.24
$9.01
50-Day Range
$7.12
$12.92
52-Week Range
$6.97
$39.49
Volume
27,657 shs
Average Volume
857,711 shs
Market Capitalization
$240.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.91

Esperion Therapeutics (NASDAQ:ESPR) SEC Filings

DateFilerForm TypeView
08/03/2021
10:05 AM
Esperion Therapeutics (Filer)
Form S-3ASR
08/03/2021
10:04 AM
Esperion Therapeutics (Filer)
Form RW
08/03/2021
8:27 AM
Esperion Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/03/2021
6:12 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2021
6:30 AM
Esperion Therapeutics (Issuer)
Foody Joanne M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
6:25 AM
Esperion Therapeutics (Issuer)
Foody Joanne M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/30/2021
3:27 PM
Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
4:00 PM
BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
Form SC 13G/A
05/28/2021
3:19 PM
Berkowitz Jeffrey (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
3:19 PM
Esperion Therapeutics (Issuer)
Fuhrman Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
3:18 PM
Esperion Therapeutics (Issuer)
MCGOVERN MARK E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
3:18 PM
Esperion Therapeutics (Issuer)
Shepard Jay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
3:18 PM
Esperion Therapeutics (Issuer)
GOTTO ANTONIO M JR MD D PHIL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
3:04 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/26/2021
10:53 AM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2021
1:06 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2021
8:09 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2021
2:23 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
4:21 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2021
4:00 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2021
4:17 PM
Esperion Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/23/2021
4:15 PM
Esperion Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/23/2021
3:15 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2021
12:03 PM
Esperion Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/09/2021
1:56 PM
Esperion Therapeutics (Subject)
WASATCH ADVISORS INC (Filed by)
Form SC 13G/A
01/29/2021
4:01 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2021
4:01 PM
Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2021
4:01 PM
Esperion Therapeutics (Issuer)
Hall Ashley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2021
4:00 PM
Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
6:00 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2021
1:37 PM
Esperion Therapeutics (Subject)
Meditor Group Ltd (Filed by)
Form SC 13G/A
12/31/2020
3:09 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
6:36 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2020
6:48 AM
Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/15/2020
6:32 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2020
1:36 PM
Esperion Therapeutics (Subject)
WASATCH ADVISORS INC (Filed by)
Form SC 13G
11/16/2020
4:15 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2020
6:01 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2020
3:37 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2020
4:21 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2020
3:28 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
4:18 PM
Esperion Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/10/2020
4:16 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/22/2020
7:00 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2020
3:44 PM
Esperion Therapeutics (Subject)
MARSHALL WACE, LLP (Filed by)
Form SC 13G
05/29/2020
3:42 PM
Berkowitz Jeffrey (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
3:41 PM
Esperion Therapeutics (Issuer)
Fuhrman Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
3:32 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2020
4:26 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/20/2020
7:01 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2020
9:34 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/06/2020
6:15 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2020
7:07 AM
Esperion Therapeutics (Issuer)
Fuhrman Alan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2020
7:00 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2020
6:34 AM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
5:16 AM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
6:30 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2020
4:12 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2020
11:51 AM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
7:23 AM
Esperion Therapeutics (Subject)
Meditor Group Ltd (Filed by)
Form SC 13G/A
01/03/2020
3:27 PM
Esperion Therapeutics (Issuer)
Glickman Mark A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
3:27 PM
Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
3:27 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2019
1:54 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
3:30 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
7:30 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2019
3:22 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2019
3:09 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2019
3:30 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
3:32 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
7:00 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2019
11:42 AM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
3:57 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
4:18 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
5:09 PM
Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:52 PM
Esperion Therapeutics (Issuer)
Woody Tracy M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:52 PM
Braunstein Scott (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:52 PM
Berkowitz Jeffrey (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:51 PM
Esperion Therapeutics (Issuer)
JANNEY DANIEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:51 PM
Esperion Therapeutics (Issuer)
GOTTO ANTONIO M JR MD D PHIL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:50 PM
Esperion Therapeutics (Issuer)
MCGOVERN MARK E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:50 PM
Esperion Therapeutics (Issuer)
Shepard Jay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:49 PM
Esperion Therapeutics (Issuer)
Woody Tracy M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/30/2019
3:32 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2019
3:30 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2019
3:32 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2019
7:01 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
3:30 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2019
3:32 PM
Esperion Therapeutics (Filer)
Form DEF 14A
04/05/2019
4:23 PM
Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
3:41 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2019
4:01 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2019
8:02 AM
Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2019
6:50 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
3:57 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
3:57 PM
Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:50 PM
Esperion Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2019
3:45 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
4:22 PM
Esperion Therapeutics (Subject)
Partner Fund Management, L.P. (Filed by)
Form SC 13G/A
02/14/2019
3:30 PM
Esperion Therapeutics (Subject)
Pentwater Capital Management LP (Filed by)
Form SC 13G/A
This page was last updated on 12/1/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.